| Oss Capital Management10% owner · 1 transaction | — | 1.92Mas of May 2007 | — | — | 82.0K |
| Anderson Steven GFormer Executive Chairman · 199 transactions | — | 1.38M†as of Apr 2015 | 770.0K | — | 461.4K |
| Mackin James PPresident & CEO · 116 transactions | — | 947.3K | 2.12M | 22.5K | 991.2K |
| Lacy Virginia CDirector · 258 transactions | — | 447.5K†as of Apr 2007 | 32.5K | — | 106.0K |
| Lee David AshleyExecutive VP, COO & CFO · 209 transactions | — | 369.8K†as of Mar 2023 | 899.3K | 6.1K | 345.5K |
| Davis John EChief Commercial Officer · 119 transactions | — | 230.8K | 402.7K | 10.6K | 144.2K |
| Berry Lance AEVP, COO, CFO & Treasurer · 12 transactions | — | 210.8K | 240.0K | — | 29.1K |
| Morgan HarveyDirector · 41 transactions | — | 194.2K†as of Aug 2021 | 111.1K | — | 10.0K |
| Holloway Jean FSVP, General Counsel · 156 transactions | — | 185.1K | 471.6K | — | 238.6K |
| Bevevino Daniel JDirector · 24 transactions | — | 157.6K | 167.6K | — | 10.0K |
| Ackerman Thomas FDirector · 26 transactions | — | 157.5K | 177.5K | — | 20.0K |
| Capps Scott BVP, Clinical Research · 79 transactions | — | 153.4Kas of Mar 2021 | 282.6K | — | 75.0K |
| Horton AmyVP, Chief Accounting Officer · 188 transactions | — | 139.1K | 420.6K | — | 182.3K |
| Salveson Jon WDirector · 17 transactions | — | 137.4K | 112.4K | 25.0K | — |
| McCall Ronald DDirector · 84 transactions | — | 121.8Kas of Aug 2021 | 195.3K | — | 175.6K |
| Heacox Albert ESr. VP Research and Devl · 32 transactions | — | 115.5K†as of Jan 2012 | 150.9K | — | 72.9K |
| Cook John MDirector · 7 transactions | — | 114.5K†as of Jun 2009 | 65.0K | — | 10.0K |
| Fronk DavidVP, Regulatory Affairs · 66 transactions | — | 110.6Kas of Mar 2015 | 252.4K | — | 71.4K |
| Anderson Bruce G.VP, US Sales &Global Marketing · 42 transactions | — | 104.1K†as of Mar 2015 | 116.8K | — | 85.8K |
| Burris Jeffrey WVice President & Gen. Counsel · 28 transactions | — | 98.6Kas of Aug 2014 | 140.3K | — | 31.0K |
| Semedo Anthony B.Director · 12 transactions | — | 94.5K† | 36.4K | 17.1K | 12.3K |
| Green Andrew MSVP, Regulatory and Quality · 25 transactions | — | 90.3K | 97.7K | — | 63.6K |
| Gale David CVP, Research & Development · 38 transactions | — | 77.1Kas of Nov 2017 | 120.7K | — | 20.3K |
| Bullock JamesDirector · 12 transactions | — | 76.2K | 63.2K | 10.0K | — |
| Lang David P.VP, Int'l Sales & Marketing · 7 transactions | — | 73.4Kas of Feb 2015 | 52.4K | — | — |
| Seery Gerald BSr. VP, Sales and Marketing · 127 transactions | — | 72.0Kas of Nov 2012 | 170.4K | — | 68.4K |
| Ronald C ElkinsDirector · 112 transactions | — | 64.8Kas of Sep 2018 | 159.3K | — | 107.2K |
| Burbank Jeffrey HDirector · 10 transactions | — | 61.4K | 57.8K | — | — |
| Stanton Marshall S.SVP, Clinical & MD Affair · 63 transactions | — | 60.1K | 224.0K | — | 164.1K |
| Borgstrom Marna PDirector · 10 transactions | — | 56.7K | 56.7K | — | — |
| Benson JamesDirector · 27 transactions | — | 54.1Kas of Oct 2017 | 103.7K | — | 42.0K |
| Maney Rochelle L.VP, Quality · 29 transactions | — | 46.6Kas of Mar 2024 | 49.6K | — | 13.5K |
| Ashmore Sidney BVice President of Marketing · 1 transaction | — | 42.7Kas of Jan 2006 | 24.0K | — | — |
| Tyrs FlorianVP, Global Operations · 5 transactions | — | 42.6K†as of Feb 2024 | 8.6K | — | 1.5K |
| Matthews William RobertSenior VP, Operations, Quality · 8 transactions | — | 40.8Kas of Mar 2018 | 35.7K | — | — |
| Getz Matthew AVP, Human Resources · 34 transactions | — | 36.7Kas of Aug 2024 | 66.6K | — | 28.5K |
| Maier Dennis BSVP, Operations · 54 transactions | — | 35.1Kas of Jun 2023 | 76.1K | — | 41.1K |
| Hoff Elizabeth ADirector · 6 transactions | — | 34.8K | 39.0K | — | 4.2K |
| Simpson Michael SSVP, Regulatory Affairs and QA · 10 transactions | — | 33.7Kas of Mar 2021 | 24.5K | — | — |
| McDermid James MSVP, CHRO · 11 transactions | — | 30.8Kas of Mar 2019 | 29.7K | — | — |
| Barthold Franz PeterVP, Research & Development · 16 transactions | — | 30.0Kas of Nov 2022 | 29.9K | — | — |
| Saurini Sherry MVP, Quality · 8 transactions | — | 25.1Kas of Mar 2019 | 8.7K | — | — |
| Bogenschuetz Thomas JVP, EMEA & General Manager · 6 transactions | — | 23.5Kas of Mar 2020 | 12.1K | — | — |
| Thomson Robert CVP Research & Development · 2 transactions | — | 13.3Kas of Feb 2024 | 13.3K | — | — |
| Van Dyne Bruce J MDDirector · 1 transaction | — | 12.8Kas of Aug 2006 | 2.5K | — | — |
| Theodore Philip AVP, General Counsel · 1 transaction | — | 8.1Kas of Sep 2007 | 15.0K | — | — |